Article
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Leukemia & lymphoma - 1 Dec 2022
Lontos Konstantinos, Tsagianni Anastasia, Agha Mounzer, Raptis Anastasios, Hou Jing-Zhou, Farah Rafic, Redner Robert L, Im Annie, Dorritie Kathleen A, Sehgal Alison, Rossetti James, Aggarwal Nidhi, Saul Melissa, Gooding William, Boyiadzis Michael
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
